{
    "doi": "https://doi.org/10.1182/blood-2021-146826",
    "article_title": "Comparable Outcomes Among Adult Patients Allotransplanted for Myelodysplastic Syndrome Using Haploidentical, Matched Unrelated or Matched Sibling Donors: A Single-Center Study ",
    "article_date": "November 5, 2021",
    "session_type": "732.Allogeneic Transplantation: Disease Response and Comparative Treatment Studies",
    "abstract_text": "Introduction : Allogeneic stem cell transplantation (allo-SCT) remains the only curative option for patients with myelodysplastic syndrome (MDS). If recent data have shown encouraging results with haploidentical (haplo) donors in this context, no comparison with allo-SCT using other source of graft (matched sibling [MSD] or unrelated [MUD] donors) has been reported so far. Methods : We retrospectively considered 102 consecutive adults transplanted for MDS between March 2010 and August 2020 in our Department, comparing outcomes between those receiving a graft from a MSD, a MUD or a haplo-donor. Results : Thirty-three, 48 and 21 patients respectively received a graft from a MSD, MUD or haplo donor. Peripheral blood stem cells (PBSC) were the source of graft for all patients. The median age of the whole cohort was 63 years old (range: 20-74) and the median follow-up was 23 months (range: 0-125). The three groups shared similar characteristics (gender, type of MDS, disease status, disease risk index, CMV status, ABO compatibility, peripheral blood stem cells graft count, conditioning regimen) except median recipient age which was younger in matched patients ( 61 vs 65 MUD vs 65 Haplo, p=0,04) and median donor age which was older in matched transplant ( 61 vs 34 MUD vs 42 Haplo, p< 0,001) (Table 1). With a median follow-up of 46,4 months, the 4-year OS (Figure 1) was comparable between the three groups (haplo: 60.1 % \u00b1 11,0 % , MSD: 59,0 % \u00b19,4 % and MUD: 61.2 % \u00b1 7,2 %, p = 0.88) as well as the 4-year DFS (Figure 2) (55.9 % \u00b1 11,1 % vs 51,2 % \u00b19,2 % vs 59.6 % \u00b1 7,2 %, p = 0.78) and the cumulative incidence (CI) of NRM (34.6 % \u00b112,4 % , 15,4% \u00b1 6,4% and 23.8 % \u00b1 6,4 %, p = 0.21). Also, the 4-year CI of acute grade 3-4 GVHD (14,3% vs 15,2% vs 20,8%, p=0.79) and of moderate/severe chronic GVHD (14,3% vs 24.2% vs 27,1%, p=0.56) were not significantly different. The 4-year GRFS seemed better with haplo (Figure 3) but this was not statistically significant (56,1 % \u00b1 11,0% vs 28,1% \u00b19,2 % vs 32,8 % \u00b1 7,4%,p=0 .41). Conclusions : These data suggest that haplo-identical donors represent a valid alternative in MDS patients lacking a MSD or a MUD for allo-SCT. Figure 1 View large Download slide Figure 1 View large Download slide Close modal Disclosures Moreau:  Oncopeptides: Honoraria; Amgen: Honoraria; Celgene BMS: Honoraria; Janssen: Honoraria; Sanofi: Honoraria; Abbvie: Honoraria.",
    "author_names": [
        "Alice Garnier",
        "Maxime Jullien",
        "Thierry Guillaume",
        "Pierre Peterlin",
        "Amandine Le Bourgeois",
        "B\u00e9atrice Mah\u00e9",
        "Viviane Dubruille",
        "Nicolas Blin",
        "Cyrille Touzeau",
        "Thomas Gastinne",
        "Anne Lok",
        "Benoit Tessoulin",
        "Sophie Vantyghem",
        "Marie C Bene",
        "Philippe Moreau",
        "Steven Le Gouill",
        "Patrice Chevallier"
    ],
    "author_dict_list": [
        {
            "author_name": "Alice Garnier",
            "author_affiliations": [
                "Department of Hematology, Nantes University Hospital, Nantes, France"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Maxime Jullien",
            "author_affiliations": [
                "CHU de Nantes, Nantes, France"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Thierry Guillaume",
            "author_affiliations": [
                "Clinical Hematology, Nantes University Hospital, Nantes, France"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pierre Peterlin",
            "author_affiliations": [
                "Clinical Hematology, Nantes University Hospital, Nantes, France"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Amandine Le Bourgeois",
            "author_affiliations": [
                "Nantes University Hospital, NANTES, France"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "B\u00e9atrice Mah\u00e9",
            "author_affiliations": [
                "Centre Hospitalier Universitaire de Nantes, Nantes, France"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Viviane Dubruille",
            "author_affiliations": [
                "Clinical Hematology, Nantes University Hospital, Nantes, France"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nicolas Blin",
            "author_affiliations": [
                "Clinical Hematology, Nantes University Hospital, Nantes, France"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Cyrille Touzeau",
            "author_affiliations": [
                "Hematology Clinic, University Hospital H\u00f4tel-Dieu, Nantes, France"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Thomas Gastinne",
            "author_affiliations": [
                "Clinical Hematology, Nantes University Hospital, Nantes, France"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anne Lok",
            "author_affiliations": [
                "Clinical Hematology, Nantes University Hospital, Nantes, France"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Benoit Tessoulin",
            "author_affiliations": [
                "Universit\u00e9 de Nantes, CNRS, INSERM, CRCINA, Nantes, France, Nantes, France"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sophie Vantyghem",
            "author_affiliations": [
                "Clinical Hematology, Nantes University Hospital, Nantes, France"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marie C Bene",
            "author_affiliations": [
                "Hematology Biology, Nantes University Hospital, Nantes, France"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Philippe Moreau",
            "author_affiliations": [
                "University Hospital H\u00f4tel-Dieu, Nantes, France"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Steven Le Gouill",
            "author_affiliations": [
                "Service d'h\u00e9matologie clinique du CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Universit\u00e9 de Nantes, Nantes, France"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Patrice Chevallier",
            "author_affiliations": [
                "Department of Clinical Hematology, Nantes University Hospital, Nantes, France"
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-21T09:40:49",
    "is_scraped": "1"
}